New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
出版年份 2019 全文链接
标题
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 17, Pages 4136
出版商
MDPI AG
发表日期
2019-08-26
DOI
10.3390/ijms20174136
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Modulation of RAB7A Protein Expression Determines Resistance to Cisplatin through Late Endocytic Pathway Impairment and Extracellular Vesicular Secretion
- (2019) Flora Guerra et al. Cancers
- Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
- (2019) Camilla Salvagno et al. NATURE CELL BIOLOGY
- Cancer-associated fibroblasts contribute to cisplatin resistance via modulating ANXA3 in lung cancer cells
- (2019) Limin Wang et al. CANCER SCIENCE
- Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling
- (2019) Xingbo Long et al. Cell Death & Disease
- Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview
- (2019) Muhammad Asim Farooq et al. Artificial Cells Nanomedicine and Biotechnology
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
- (2019) Jing Zhai et al. CANCER LETTERS
- Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis
- (2018) Yu-Hsuan Lai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer
- (2018) Matthias Villalobos et al. MEDICAL ONCOLOGY
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells
- (2018) Akansha Jalota et al. Oncotarget
- Nanotechnology: a promising method for oral cancer detection and diagnosis
- (2018) Xiao-Jie Chen et al. JOURNAL OF NANOBIOTECHNOLOGY
- Hypoxia promotes acquisition of aggressive phenotypes in human malignant mesothelioma
- (2018) Myung-Chul Kim et al. BMC CANCER
- The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
- (2018) Dimakatso Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low Expression of Excision Repair Cross-complementation Group-1 Protein Predicts Better Outcome in Patients with Locally Advanced Nasopharyngeal Cancer Treated with Concurrent Chemoradiotherapy
- (2018) Zhongxin Zhang et al. TUMORI
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy
- (2017) Hyewon Ryu et al. MEDICINE
- IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
- (2017) Y Qiao et al. ONCOGENE
- Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells
- (2017) Priya Samuel et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
- (2016) E. Beyranvand Nejad et al. CANCER RESEARCH
- Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
- (2016) Norihiro Sato et al. CANCER SCIENCE
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
- (2016) Weimin Wang et al. CELL
- Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment
- (2016) Ping-Pui Wong et al. CURRENT BIOLOGY
- Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain
- (2016) Helena Öhrvik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-induced resistance to cisplatin-mediated apoptosis in osteosarcoma cells is reversed by gambogic acid independently of HIF-1α
- (2016) Wei Zhao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma
- (2016) Hongfang Zhang et al. MOLECULAR CARCINOGENESIS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin
- (2016) Harvey I. Pass et al. Oncotarget
- Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
- (2016) Szu-Jung Chen et al. Oncotarget
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
- (2016) Carman K. M. Ip et al. Scientific Reports
- Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
- (2015) Szu-Jung Chen et al. BIOCHEMICAL PHARMACOLOGY
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma
- (2015) D. W. Cescon et al. CLINICAL CANCER RESEARCH
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy
- (2015) Helen HW Chen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma
- (2015) Shang Hung Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis
- (2015) Ma Xuelei et al. ORAL ONCOLOGY
- Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer
- (2015) TIAN YANG et al. Oncology Letters
- Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy
- (2014) Zheng Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
- (2014) A. R. de Biasi et al. CLINICAL CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
- (2014) Eric S. Kim et al. LUNG CANCER
- The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
- (2014) Annette Hayden et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies
- (2013) Siqing Fu et al. INVESTIGATIONAL NEW DRUGS
- Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–Small-Cell Lung Cancer: AVAPERL (MO22089)
- (2013) Fabrice Barlesi et al. JOURNAL OF CLINICAL ONCOLOGY
- Rethinking the war on cancer
- (2013) Douglas Hanahan LANCET
- Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
- (2012) Connie Jackaman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The tumor microenvironment is a dominant force in multidrug resistance
- (2012) Ana Luísa Correia et al. DRUG RESISTANCE UPDATES
- Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum
- (2012) Julie A. DeLoia et al. GYNECOLOGIC ONCOLOGY
- Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
- (2012) Magali Castells et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy
- (2012) Jing Huang et al. MEDICAL ONCOLOGY
- Subcellular targets of cisplatin cytotoxicity: An integrated view
- (2012) Sandra M. Sancho-Martínez et al. PHARMACOLOGY & THERAPEUTICS
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients
- (2011) I. G. Hwang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck
- (2011) Alec Vaezi et al. CLINICAL CANCER RESEARCH
- Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy
- (2011) Yoo-Young Lee et al. GYNECOLOGIC ONCOLOGY
- An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
- (2011) M. A. Lowery et al. ONCOLOGIST
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy
- (2010) Bernd Kaina et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype
- (2010) Charlie Gourley et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Interaction of Cisplatin with the Human Organic Cation Transporter 2
- (2008) K. K. Filipski et al. CLINICAL CANCER RESEARCH
- Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
- (2008) Amelie Rebillard et al. CURRENT MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now